Article info

Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

Authors

  • Tricia Cottrell Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Queen's Cancer Research Institute at Queens University, Kingston, Ontario, Canada PubMed articlesGoogle scholar articles
  • Jiajia Zhang Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Boyang Zhang Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Genevieve J Kaunitz Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Poromendro Burman Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Hok-Yee Chan Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Franco Verde Department of Radiology, Johns Hopkins School of Medicine, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Jody E Hooper Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Hans Hammers Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA PubMed articlesGoogle scholar articles
  • Mohamad E Allaf Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Hongkai Ji Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Janis Taube Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA The Mark Foundation Center for Advanced Genomics and Imaging, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  • Kellie N Smith Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, MD, USA Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA The Mark Foundation Center for Advanced Genomics and Imaging, Baltimore, MD, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kellie N Smith; ksmit228{at}jhmi.edu
View Full Text

Citation

Cottrell T, Zhang J, Zhang B, et al
Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

Publication history

  • Accepted June 2, 2021
  • First published July 6, 2021.
Online issue publication 
July 06, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.